Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer

Bio2RDF uri

Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer

http://bio2rdf.org/clinicaltrials:NCT01540045

Bio2RDF identifier

NCT01540045

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT01540045

http://www.w3.org/2001/XMLSchema#string

brief summary [clinicaltrials_vocabulary:brief-summary]

One of the most widely ...... l status and quality of life.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Effect of Chemotherapy With Pa ...... in Non Small Cell Lung Cancer

http://www.w3.org/2001/XMLSchema#string

clinical result [clinicaltrials_vocabulary:clinical-result]

clinical results for clinicaltrials:NCT01540045 [clinicaltrials_resource:c68ec0f9ebf8220da9c2544ac1d0cc98]

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:01859aee05529e52a89cef3fba7aa56c]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:3e1dde84529e0b32ed535a2d6a27e019]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:448597aeedf0c02f7195105bcc2bb3d1]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:481bed058ebf4398e415281644dbab67]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:531ed302474ed0b24d31b6316c1587fa]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:578577445f6d7b7561a5286b3562c250]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:78da20cad209728088589f1560422ee3]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:dd97f00b3c69c4f30a14b481b2f2ebed]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:f182fcc25646b0bb09045c80a34fc6bc]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:1c9526ebcc7f01d6c9c93764fe21574e]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:22e0ef399659b85af797ec5f88f88c01]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:2486e781517fd4d1bc90131ecee184bf]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:3e059dbc012a17eaeac88a5fadc3b5f2]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:7c305b2d23e617b52a5ded59adaaa455]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:90026a65ad06207b1b45c9f9ac1cf3ad]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:9fd6156848fdb7b495675e400f9f343d]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:d4baa634766cb9b204b5f1f1f57cc6c9]

Dysgeusia (UMAMI Perception) Change from Baseline in threshold of perception at 6 weeks [clinicaltrials_resource:db60dd5b72395255568f1260914f7e37]

completion date [clinicaltrials_vocabulary:completion-date]

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

Small Cell Lung Carcinoma [clinicaltrials_resource:00d4d384c3a612aee30588f8980ad052]

Dysgeusia [clinicaltrials_resource:93689cdac895cc0252f8f5722026c871]

Non-Small Cell Lung Cancer [clinicaltrials_resource:ab14773ed54a09fa58d253c460bc3881]

Taste Disorders [clinicaltrials_resource:adadf44c0cc1d13ce9e09a5c4ffbee8f]

Lung Neoplasms [clinicaltrials_resource:d4c66a654b5be56235c9510d8a05fe76]

condition browse [clinicaltrials_vocabulary:condition-browse]

Small Cell Lung Carcinoma [clinicaltrials_resource:00d4d384c3a612aee30588f8980ad052]

Dysgeusia [clinicaltrials_resource:93689cdac895cc0252f8f5722026c871]

Carcinoma, Non-Small-Cell Lung [clinicaltrials_resource:99b0a5f0aed6373c525dfbd858bd5588]

Taste Disorders [clinicaltrials_resource:adadf44c0cc1d13ce9e09a5c4ffbee8f]

Lung Neoplasms [clinicaltrials_resource:d4c66a654b5be56235c9510d8a05fe76]

condition mesh [clinicaltrials_vocabulary:condition-mesh]

Small Cell Lung Carcinoma [clinicaltrials_resource:00d4d384c3a612aee30588f8980ad052]

Dysgeusia [clinicaltrials_resource:93689cdac895cc0252f8f5722026c871]

Carcinoma, Non-Small-Cell Lung [clinicaltrials_resource:99b0a5f0aed6373c525dfbd858bd5588]

Taste Disorders [clinicaltrials_resource:adadf44c0cc1d13ce9e09a5c4ffbee8f]

Lung Neoplasms [clinicaltrials_resource:d4c66a654b5be56235c9510d8a05fe76]

country [clinicaltrials_vocabulary:country]

Mexico [clinicaltrials_resource:8dbb07a18d46f63d8b3c8994d5ccc351]

detailed description [clinicaltrials_vocabulary:detailed-description]

Lung cancer is the lead ...... same regimen of chemotherapy.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT01540045 [clinicaltrials_resource:ee4510a581de151f36f6477681bb1aa7]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2012-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

firstreceived results date [clinicaltrials_vocabulary:firstreceived-results-date]

2013-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Paclitaxel [clinicaltrials_resource:9fab0945b0ae4f7c78a778811b9935ca]

Cisplatin [clinicaltrials_resource:b8c8989cecf98bb7fbbfc2be8c78bee6]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Antineoplastic Combined Chemotherapy Protocols

http://www.w3.org/2001/XMLSchema#string

Cisplatin

http://www.w3.org/2001/XMLSchema#string

Dysgeusia

http://www.w3.org/2001/XMLSchema#string

Non-Small Cell Lung Cancer

http://www.w3.org/2001/XMLSchema#string

Paclitaxel

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2015-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Instituto Nacional de Cancerologia de Mexico [clinicaltrials_resource:994da79e01c156da73d91639840d8b3b]

location [clinicaltrials_vocabulary:location]

National Cancer Institute of Mexico [clinicaltrials_resource:7bbda4326f9c57574a1a748578f41854]

nct id [clinicaltrials_vocabulary:nct-id]

NCT01540045

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Effect of Chemotherapy With Pa ...... mall Cell Lung Cancer Patients

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

ECPCDLC2012

http://www.w3.org/2001/XMLSchema#string

outcome [clinicaltrials_vocabulary:outcome]

Dysgeusia (UMAMI Perception) [clinicaltrials_resource:NCT01540045/outcome/1]

overall official [clinicaltrials_vocabulary:overall-official]

Oscar G Arrieta, MD M Sc [clinicaltrials_resource:26607bc4ee3296f8c753437319260713]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Mexico: Ethics Committee [clinicaltrials_resource:64e14b2f6685021351fbc469566b6d1e]

participant flow [clinicaltrials_vocabulary:participant-flow]

participant flow for clinicaltrials:NCT01540045 [clinicaltrials_resource:c251cf7cabd80297f993cb1668887d9c]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reference [clinicaltrials_vocabulary:reference]

10736361 [pubmed:10736361]

11762967 [pubmed:11762967]

11963449 [pubmed:11963449]

12122555 [pubmed:12122555]

14649565 [pubmed:14649565]

17394940 [pubmed:17394940]

17659812 [pubmed:17659812]

17710445 [pubmed:17710445]

19175932 [pubmed:19175932]

19408458 [pubmed:19408458]

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:ef4ca293bdaa817554f3195361951596]

source [clinicaltrials_vocabulary:source]

Instituto Nacional de Cancerologia de Mexico [clinicaltrials_resource:994da79e01c156da73d91639840d8b3b]

start date [clinicaltrials_vocabulary:start-date]

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT01540045 study design [clinicaltrials_resource:fa4a284229f48532d1bb258b99f1b7f2]

study type [clinicaltrials_vocabulary:study-type]

Observational [clinicaltrials_resource:d91f8943e6c920253e1301b3d81445a1]

url [clinicaltrials_vocabulary:url]

NCT01540045

verification date [clinicaltrials_vocabulary:verification-date]

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT01540045

http://www.w3.org/2001/XMLSchema#string

title

Effect of Chemotherapy With Pa ...... in Non Small Cell Lung Cancer

@en